The prevalence and long term outcome of occult hepatitis B virus infections in community based populations

Journal of Medical Virology

Volumn 84, Issue 9, 2012, Pages 1369-1375

  Minuk, G Y ^a   Kowalec, K ^b   Caouette, S ^a   Larke, B ^c   Osiowy, C ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cirrhosis; Hepatitis; Hepatitis B; Hepatocellular carcinoma; Liver; Liver disease; Occult hepatitis B

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; OCCULT HEPATITIS B; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEROLOGY; VIRUS LOAD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; NORTHWEST TERRITORIES; PHYLOGENY; PREVALENCE; RURAL POPULATION; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84864133194     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23351     Document Type: Article

References (43)

1. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. 2008. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Scand J Gastroenterol 43: 849-856.
2. Baleriola C, Johal H, Jacka B, Chaverot S, Bowden S, Lacey S, Rawlinson W. 2011. Stability of HCV, HIV and HBV nucleic acid in plasma samples after long-term storage at -20°C and -70°C. J Clin Microbiol [Epub ahead of print].
3. Blackberg J, Kidd-Ljunggren K. 2000. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 33: 992-997.
4. Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V. 2010. Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. J Med Virol 82: 206-212.
5. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. 2001. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult?" Hepatology 34: 194-203.
6. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. 2004. Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter. Gastroenterology 127: 1356-1371.
7. Chemin I, Trepo C. 2005. Clinical impact of occult HBV infections. J Clin Virol 34: S15-S21 (Review).
8. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, Bedossa P, FIBROSTIC study group. 2010. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 53: 1013-1021.
9. Grubel P. 2011. Evaluation of abdominal ultrasound performed by the gastroenterologist in the office. J Clin Gastroenterol 45: 405-409.
10. Hu KQ. 2002. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9: 243-257 (Review).
11. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. 2009. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: A cohort study. J Viral Hepat 16: 437-443.
12. Larke B, Froese GJ, Devine RD, Petruk MW. 1987. Extension of the epidemiology of hepatitis B in circumpolar regions through a comprehensive serologic study in the Northwest Territories of Canada. J Med Virol 22: 269-276.
13. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
14. Lee HS, Kim JK, Cheong JY, Han EJ, An SY, Song JH, Jung YJ, Jeon SC, Jung MW, Jang EJ, Cho SW. 2010. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol 16: 369-375.
15. Lindh M, Furuta Y, Ljunggren KK, Norkrans G, Horal P. 1995. Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method. J Infect Dis 171: 194-197.
16. Liu Y, Li P, Li C, Zhou J, Wu C, Zhou YH. 2010. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J 7: 193.
17. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR, HALT-C Trial Group. 2011. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology 54: 434-442.
18. Ma JX, Lu HZ, Wang JR, Zhang RF, Zheng YF, Liu L, Qi TK, Shen YZ. 2008. A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients. Zhonghua Nei Ke Za Zhi 47: 574-577.
19. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. 1994. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 93: 230-239.
20. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, Gutkin A, Bernstein K, Giulivi A, Osiowy C. 2004. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40: 1072-1077.
21. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. 2005. Occult hepatitis B virus infection in a North American community-based population. J Hepatol 42: 480-485.
22. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
23. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. 2006. Molecular evolution of hepatitis B virus over 25 years. J Virol 80: 10307-10314.
24. Osiowy C, Larke B, Giles E. 2011. Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey. J Viral Hepat 18: e11-e19.
25. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. 2004. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126: 102-110.
26. Raimondo G, Pollicino T, Squadrito G. 2005. What is the clinical impact of occult hepatitis B virus infection? Lancet 365: 638-640.
27. Raimondo G, Pollicino T, Cacciola I, Squadrito G. 2007. Occult hepatitis B virus infection. J Hepatol 46: 160-170.
28. Raimondo G, Pollicino T, Romano L, Zanetti AR. 2010. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris) 58: 254-257.
29. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. 1996. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxoic T-lymphocyte response. Nat Med 2: 1004-1008.
30. Sakamoto T, Tanaka Y, Simonetti J, Osiowy C, Borresen ML, Koch A, Kurbanov F, Sugiyama M, Minuk GY, McMahon BJ, Joh T, Mizokami M. 2007. Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. J Infect Dis 196: 1487-1492.
31. Sanlidag T, Akcali S, Ozbakkaloglu B. 2005. Serum hepatitis B DNA: Stability in relation to multiple freeze-thaw procedures. J Virol Methods 123: 49-52.
32. Schmeltzer P, Sherman KE. 2010. Occult hepatitis B: Clinical implications and treatment decisions. Dig Dis Sci 55: 3328-3335.
33. Solar K, Minuk GY, Borresen ML, Koch A, McMahon BJ, Simons B, Osiowy C. 2010. Association between hepatitis B virus longitudinal genetic variability and clinical outcome in circumpolar indigenous populations (Abstract 1385). Hepatology 52: 987A.
34. Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, Rossau R. 2000. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 38: 702-707.
35. Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M. 2004. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol 85: 811-820.
36. Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, Ueda R, Mizokami M. 2011. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. J Med Virol 83: 412-418.
37. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, Yoshizawa H, Mishiro S. 1995. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: Clinical significance and an easy method for detection. J Gen Virol 76: 3159-3164.
38. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
39. Yeshua H, Oren R. 2008. Non invasive assessment of liver fibrosis. Ann Transplant 13: 5-11.
40. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Kimura S, Koike K. 1998. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27: 1377-1382.
41. Yuen MF, Lee CK, Wong DK, Fung J, Hung I, Hsu A, But DY, Cheung TK, Chan P, Yuen JC, Fung FK, Seto WK, Lin CK, Lai CL. 2010. Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor population. Gut 59: 1389-1393.
42. Yuen MF, Wong DK, Lee CK, Tanaka Y, Allain JP, Fung J, Leung J, Lin CK, Sugiyama M, Sugauchi F, Mizokami M, Lai CL. 2011. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis 52: 624-632.
43. Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K, Omura M, Hikiji K, Kato M. 2003. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 37: 1172-1179.